Iso - Inst. Santista de Oncologia

Santos, São Paulo 11075-350

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Breast Cancer

Studies at this site

• A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer — Completed